Zobrazeno 1 - 10
of 27
pro vyhledávání: '"A. V. Soldatenkova"'
Autor:
A. V. Soldatenkova, A. M. Kudryashova, N. F. Gavrilova, I. V. Yakovleva, O. V. Borisova, V. V. Sviridov, N. A. Mikhailova
Publikováno v:
Медицинская иммунология, Vol 22, Iss 4, Pp 805-810 (2020)
A hybrid recombinant protein containing the amino acid sequences of the three most significant Pseudomonas aeruginosa antigens (membrane proteins OprF, OprI and toxoid aTox) was incorporated into a vaccine against Pseudomonas infection. Quality contr
Externí odkaz:
https://doaj.org/article/cc54e82b58554f6f990de72029ea75e1
Publikováno v:
Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 1, Iss 1, Pp 74-80 (2019)
Aim. The aim is obtaining, investigation and selection of recombinant antigens for inclusion theirs into the against Pseudomonas vaccine. Materials and methods. The genes encoding of the outer membrane proteins F, L and I and Exotoxin A were synthesi
Externí odkaz:
https://doaj.org/article/8ab67ee53612451eb93eccd6382cc38b
Autor:
A. V. Soldatenkova, E. M. Zimina, A. M. Kudryashova, N. F. Gavrilova, I. V. Yakovleva, O. V. Borisova, V. V. Sviridov, N. A. Mikhailova
Publikováno v:
Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 1, Iss 1, Pp 95-100 (2019)
Aim. Development and optimization of enzyme immunoassays for quality control of pseudomonas recombinant vaccine. Materials and methods. Recombinant proteins in intermediate products and for completeness of adsorption control were detected in sandwich
Externí odkaz:
https://doaj.org/article/b08fa818fb4b4183855f38e4345cb6df
Publikováno v:
Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 0, Iss 6, Pp 31-37 (2018)
Aim. Evaluation of the efficacy and safety of the three experimental lots of Recombinant Pseudomonas Vaccine. Materials and methods. The preparation contained the recombinant proteins OprF and toxoid that were purified by chromatography in nickel-sep
Externí odkaz:
https://doaj.org/article/611219979b8d4c9f948d79b89835d441
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 16, Iss 2, Pp 96-100 (2018)
Into the cells of Escherichia coli (strain BL21(DE3)) two forms of the fusion protein Pseudomonas aeruginosa containing the full length outer membrane protein F (OprF) and nontoxic form of Exotoxin A (without 106 C-terminal amino acid residues) have
Externí odkaz:
https://doaj.org/article/b285aaf19e234dc2b8d9a0b617dfc9d0
Publikováno v:
Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 0, Iss 5, Pp 32-38 (2017)
Aim. Obtaining fused recombinant proteins of Pseudomonas aeruginosa that have protective properties against experimental pseudomonas infection. Materials and methods. Fused sequences of P. aeruginosa genes oprF, oprl and deleted form of toxA were clo
Externí odkaz:
https://doaj.org/article/cbdf129c8a714b379e6b2c81138219af
Publikováno v:
Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 0, Iss 3, Pp 52-58 (2017)
Aim. Study the effect of recombinant antigens of P. aeruginosa on key effectors of the immune system. Materials and methods. Mice were immunized intraperiotoneally with 25 jig of OprF and 50 jig of anatoxin sorbed on aluminium hydroxide gel with a 2
Externí odkaz:
https://doaj.org/article/33e8380fce79418182e2e9a66dee12bd
Autor:
P. Tomasini, A. Drilon, V. Subbiah, O. Gautschi, F. Braud de, B. Solomon, D. Shao-Weng Tan, G. Alonso, J. Wolf, K. Park, K. Goto, V. Soldatenkova, S. Szymczak, S.S. Barker, T. Puri, A. Bence Lin, H. Loong, B. Besse
Publikováno v:
Revue des Maladies Respiratoires Actualités. 15:228-229
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47199eeeb6815d2c0f3482a488d3e537
https://doi.org/10.1016/j.rmra.2022.11.412
https://doi.org/10.1016/j.rmra.2022.11.412
Autor:
M. Kroiss, E.J. Sherman, L.J. Wirth, M.E. Cabanillas, B. Robinson, V. Subbiah, A.E. Drilon, Y. Godbert, N. Fasnacht, V. Soldatenkova, M.S. Xia, C-W. Duann, J. Wright, D. Weiler-Bisig, M. Shah
Publikováno v:
Annals of Oncology. 33:S1299-S1300
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4d4adcf52af7bed6d4f5a52b78ee77f
https://doi.org/10.1016/j.annonc.2022.07.1736
https://doi.org/10.1016/j.annonc.2022.07.1736
Autor:
Natalia A. Mihailova, Alexei A. Kaloshin, Ekaterina M. Zimina, Alena V. Soldatenkova, Evgeniy O. Kalinichenko, Olga V. Borisova
Publikováno v:
KnE Life Sciences.
For an aim to prevent Pseudomonas aeruginosa, a candidate recombinant vaccine has been developed. This vaccine – (RPV) was based on two protective proteins of P. aeruginosa: the outer membrane protein F (OprF) and the recombinant truncated form of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96bf19fc013edd46d8d0d214d0dc779a
https://doi.org/10.18502/kls.v7i1.10473
https://doi.org/10.18502/kls.v7i1.10473